Salvatore G Viscomi

Mar 6, 2025 | hcplive.com | Abigail Brooks |Pranav S. Garimella |Salvatore G Viscomi |Joseph A. Vassalotti |Aja Best

Our mini-docuseries has returned, taking a comprehensive look at public health crises affecting the United States today, with global implications tomorrow. If the crisis point is the moment where a crisis will worsen or begin to get better, the question remains: where are we now?

Mar 5, 2025 | consultantlive.com | Abigail Brooks |Pranav S. Garimella |Salvatore G Viscomi |Joseph A. Vassalotti |Aja Best

Our mini-docuseries has returned, taking a comprehensive look at public health crises affecting the United States today, with global implications tomorrow. If the crisis point is the moment where a crisis will worsen or begin to get better, the question remains: where are we now?

Feb 14, 2025 | forbes.com | Salvatore G Viscomi

Salvatore Viscomi MD, CEO and cofounder of Carna Health, is an entrepreneur with a passion for digital health. As the burden of chronic kidney disease (CKD) continues to escalate globally, the increasing demand for specialized care is intensifying the burden of the nephrology workforce shortage. CKD impacts around 850 million people worldwide, and shockingly, nearly , exacerbating the challenge.

Feb 12, 2025 | medcitynews.com | Salvatore G Viscomi |Stephanie Baum

Chronic Kidney Disease (CKD) is a widespread and underrecognized health crisis that silently affects millions of people, often progressing without noticeable symptoms until it’s advanced. Around 90 percent of people with CKD are unaware of their condition and only 30 percent of those with common risk factors are regularly screened for it and yet, there are no evidence-based recommendations on clinical preventive services for the disease.

Nov 8, 2024 | forbes.com | Salvatore G Viscomi

Salvatore Viscomi MD, CEO and cofounder of Carna Health, is an entrepreneur with a passion for digital health. Chronic kidney disease (CKD) is increasingly recognized as a major global health issue, and disparities in healthcare access play a critical role in this crisis. These disparities, deeply rooted in social and economic inequities, lead to significant differences in CKD prevalence and outcomes across various populations globally.